Morton Collins Net Worth & Insider Trades
Morton Collins - Director, Inovio Pharmaceuticals, Inc
What is Morton Collins's Net Worth?
The current estimated net worth of Inovio Pharmaceuticals, Inc's Director, Morton Collins, is estimated to be about $2.39M . Morton Collins owns about 114,750 units of Inovio Pharmaceuticals, Inc common stock. In the last 10 years at Inovio Pharmaceuticals, Inc, Morton Collins has sold an estimated value of $0 worth.
What is Morton Collins's Past Insider Trading?
Morton Collins's largest purchase order was 68,400 units , worth over $650.92K on April 18, 2016. In total, Morton Collins has made about 24 transactions over 10 years of their time at Inovio Pharmaceuticals, Inc. Morton Collins usually trades in May, with the busiest year in 2011. The most recent transaction was a purchase order of 21,300 units , worth over $133.19K on March 28, 2017.
Morton Collins
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Inovio Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| J. Joseph Kim, Ph.D. | 2020 | $694,645 | $3,499,999 | - | $500,032 | $13,000 | $4,707,676 |
| J. Joseph Kim, Ph.D. | 2019 | $837,735 | $638,274 | $642,803 | $457,222 | $12,500 | $2,588,534 |
| J. Joseph Kim, Ph.D. | 2018 | $726,798 | $1,545,687 | $391,922 | $407,386 | $9,250 | $3,081,043 |
| Peter D. Kies | 2020 | $445,639 | $1,499,996 | - | $198,260 | $10,010 | $2,153,905 |
| Peter D. Kies | 2019 | $523,285 | $215,096 | $216,712 | $177,833 | $10,010 | $1,142,936 |
| Peter D. Kies | 2018 | $449,886 | $354,783 | $358,612 | $158,321 | $10,010 | $1,331,612 |
| Laurent M. Humeau, Ph.D. | 2020 | $430,769 | $1,499,996 | - | $193,600 | $13,000 | $2,137,365 |
| Laurent M. Humeau, Ph.D. | 2019 | $393,903 | $199,398 | $200,970 | $165,760 | $12,500 | $972,531 |
| Jacqueline E. Shea, Ph.D. | 2020 | $430,769 | $1,499,996 | - | $193,600 | $12,946 | $2,137,311 |
| Jacqueline E. Shea, Ph.D. | 2019 | $335,000 | $181,000 | $465,120 | $165,760 | $10,154 | $1,157,034 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1055726/000105572621000033/ino-2021xproxy.htm
What are Inovio Pharmaceuticals, Inc's Past Insider Trades?
Inovio Pharmaceuticals, Inc's most recent insider trade came on March 13, 2023 by David B Weiner who sold 5,833 units worth $6.71K . In the last 17 years, insiders at Inovio Pharmaceuticals, Inc have sold an estimated value of $38.72M and bought an estimated value of $11.69M worth of shares. Insider trading is most common in May, with the busiest year in 2011 and 2021. The most active traders at the company are Jong Joseph Kim, Chief Executive Officer, Peter Kies, CFO, and David Greenhouse Austin Marxe .
INOVIO PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||